Overview Request Sample Pages Request Customization Download PDF
You are viewing: Asia Pacific Urology Devices Market analysis
Part of: Urology Devices Market (Global)

The Asia Pacific Urology Devices Market was valued at $4049.6 Million in 2025 and projected to reach to $5508.4 Million by 2030, representing a compound annual growth rate of 6.3%. The Asia Pacific urology devices market is poised for sustained growth driven by demographic shifts, rising healthcare expenditure, and increasing awareness of urological conditions.

Asia Pacific Urology Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific Urology Devices Market Trends and Insights

  • Asia Pacific represents a significant regional opportunity within the global urology devices sector, driven by rising healthcare expenditure, aging populations, and increasing prevalence of urological conditions across the region.
  • The market in Asia Pacific is characterized by growing adoption of minimally invasive procedures and advanced diagnostic technologies, supported by improving healthcare infrastructure in emerging economies. Key factors propelling growth in Asia Pacific include expanding patient awareness, rising incidence of benign prostatic hyperplasia and urinary incontinence, and increasing investment in medical device manufacturing.
  • Asia Pacific's market dynamics reflect both developed healthcare systems in countries like Japan and Australia, and rapidly developing markets in India and Southeast Asia.
  • The forecast period from 2025 to 2030 indicates sustained momentum in Asia Pacific, with technological innovation and regulatory improvements facilitating market penetration and product adoption across diverse healthcare settings..

Key Market Statistics

  • CAGR (2025-2030) 6.3% CAGR
  • Market Size, 2025 ~USD 4049.6 Million
  • Forecast, 2030 ~USD 5508.4 Million
  • Geography Asia Pacific

Asia Pacific Urology Devices Market Overview

Market Valuation & Growth Trajectory :

Asia Pacific's urology devices market is valued at $4,049.6 million in 2025 and is projected to reach $5,508.4 million by 2030, representing a robust 6.3% CAGR, outpacing the global growth rate of 6%.

China's Market Dominance :

China leads the Asia Pacific region with a market size of $3,880.8 million, accounting for approximately 96% of the regional market and driving significant innovation and manufacturing capacity across urology device segments.

Aging Population & Disease Prevalence :

Rising geriatric populations across Japan, China, and India are increasing the prevalence of benign prostatic hyperplasia, urinary incontinence, and kidney stones, creating sustained demand for advanced urological interventions and devices.

Healthcare Infrastructure Expansion :

Rapid expansion of healthcare facilities, increasing government healthcare spending, and growing medical tourism in Asia Pacific countries are accelerating adoption of advanced urology devices and minimally invasive treatment options.

Asia Pacific Urology Devices Market Dynamics

  • China's dominance as a manufacturing and consumption hub, combined with Japan's advanced medical technology adoption and India's emerging market potential, creates a diversified growth landscape.
  • Healthcare infrastructure modernization and government initiatives to improve patient access to advanced treatments are expected to accelerate market expansion through 2030. Minimally invasive procedures, robotic-assisted surgeries, and innovative diagnostic technologies are gaining traction across the region.
  • The market will benefit from strategic partnerships between global device manufacturers and local healthcare providers, coupled with regulatory improvements facilitating faster product approvals.
  • Rising disposable incomes and insurance coverage expansion in emerging economies will further drive market penetration and device adoption rates..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Asia Pacific urology devices market is valued at $4,049.6 million in 2025 with projected growth to $5,508.4 million by 2030.
    • The region demonstrates a 6.3% CAGR, outpacing global growth and reflecting strong regional demand for urological solutions.
    • Asia Pacific's market expansion is driven by aging demographics, rising healthcare spending, and increased prevalence of urological disorders.
    • Minimally invasive procedures and advanced diagnostic technologies are gaining traction across Asia Pacific healthcare systems.

    Urology Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment URINARY INCONTINENCE (UI) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 34.57 (2025)
    Revenue Forecast (Billions) ~USD 46.26 (2030)
    Segments Covered Product, Type, Application, End User

    Asia Pacific Urology Devices Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables & Accessories
    • Instruments

    By Type

    • Biopsy Devices
    • Catheters
    • Cystoscopes
    • Dialysis Consumables
    • Dialysis Devices
    • Dilator Sets & Urethral Access Sheaths
    • Drainage Bags
    • Endoscopes
    • Endoscopy Fluid Management Systems
    • Endovision & Imaging Systems
    • External Catheters
    • Guidewires
    • Hemodialysis Devices
    • Indwelling/ Foley Catheters
    • Insufflators
    • Intermittent Catheters
    • Laparoscopes
    • Laser & Lithotripsy Devices
    • Nephroscopes
    • Other Consumables & Accessories
    • Other Instruments
    • Peritoneal Dialysis Devices
    • Resectoscopes
    • Retrieval Devices & Extractors
    • Robotic Systems
    • Stents And Implants
    • Surgical Dissectors, Forceps & Needle Holders
    • Tubes & Distal Attachments
    • Ureteroscopes
    • Urodynamic Systems

    By Application

    • Benign Prostatic Hyperplasia (Bph)
    • Erectile Dysfunction
    • Kidney Diseases
    • Other Applications
    • Pelvic Organ Prolapse
    • Urinary Incontinence (Ui)
    • Urinary Stones
    • Urological Cancer

    By End User

    • Ambulatory Surgery Centers
    • Clinics
    • Dialysis Centers
    • Home Care Settings
    • Hospitals

    Target Audience

    • Medical Device Manufacturers : Urology device manufacturers need Asia Pacific market intelligence to identify expansion opportunities, assess competitive positioning, and develop region-specific product strategies in the world's fastest-growing medical device markets.
    • Healthcare Investors & PE Firms : Investment professionals require detailed market sizing, growth projections, and regional dynamics to evaluate acquisition targets, fund allocation decisions, and portfolio companies operating in Asia Pacific urology devices.
    • Hospital & Healthcare Providers : Healthcare administrators and procurement teams need market data to benchmark device costs, evaluate supplier options, plan capital equipment budgets, and optimize patient care delivery across urology departments.
    • Distributors & Supply Chain Partners : Regional distributors and logistics providers require market forecasts and country-level data to optimize inventory management, identify growth markets, and develop effective go-to-market strategies across Asia Pacific.
    • Market Research & Consulting Firms : Research organizations and consultants need comprehensive Asia Pacific market data to support client advisory services, competitive benchmarking, and strategic planning engagements in the healthcare devices sector.

    Key Companies in the Asia Pacific Urology Devices Market

    CompanyHQOwnershipStrongest segments
    SIEMENS HEALTHINEERSGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
    NOVANTA, INCUnited StatesPublic CompanyPrecision Medicine and Manufacturing (lasers, beam steering, robotic motion, end-of-arm tooling, spindles),Medical Solutions (insufflators, pumps, disposables, imaging, RFID, light engines, OR integration),
    LUMENIS LTDIsraelPrivate CompanySurgical,Ophthalmic,Aesthetic,
    MERIT MEDICALUnited StatesPublic CompanyCardiovascular (cardiac and peripheral intervention, access, hemostasis, fluid and hemodynamic management),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy),Endoscopy (gastroenterology and pulmonary, including stents, cryoballoon, dilators, kits),
    FRESENIUS MEDICAL CARE AG & CO. KGAAGermanyPublic CompanyCare Delivery (dialysis clinics and services),Dialysis equipment and disposables,Renal pharmaceuticals and ancillary services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, electrophysiology, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    B. BRAUN MELSUNGEN AGGermanyPrivate CompanyInfusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Standard and customized procedure kits,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (med-surg disposables, injection, vascular access, sharps),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Surgical Endoscopes & Integrated OR,Urology Solutions,
    CARDINAL HEALTHUnited StatesPublic CompanyBranded Pharmaceutical Distribution,Generic and OTC Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,
    INTUITIVE SURGICALUnited StatesPublic Companyda Vinci systems (capital),da Vinci instruments, accessories, and stapling/energy,Ion endoluminal system and accessories,
    COLOPLAST A/SDenmarkPublic CompanyOstomy Care (SenSura Mio, SenSura, Brava),Continence Care (SpeediCath, Conveen, Peristeen),Advanced Wound Dressings and Biologics (Biatain, Comfeel),
    STRYKERUnited StatesPublic CompanyOrthopaedics (hips, knees, shoulders, ankle, trauma and extremities, Mako Shoulder-linked implants),MedSurg equipment and patient handling (surgical equipment, patient and caregiver safety, emergency and ICU disposables),Neurotechnology and stroke care (navigation, endoscopy, stroke and venous thromboembolism treatment, brain and skull procedures),
    TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular and Emergency Medicine (Arrow, EZ-IO, FAST1, QuikClot),Interventional (coronary, structural heart, peripheral, closure, OnControl),Surgical (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),
    CONVATEC GROUP PLCUnited KingdomPublic CompanyAdvanced Wound Care,Ostomy Care,Continence Care,
    MEDTRONIC PLCIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),

    SIEMENS HEALTHINEERS

    Siemens Healthineers is a German public company founded in 1896 with 72,369 employees, operating in the healthcare technology sector.

    NOVANTA, INC

    Novanta, Inc. is a United States-based public company founded in 1968 with 3,000 employees.

    LUMENIS LTD

    Lumenis Ltd. is an Israeli private company founded in 1991 with 954 employees.

    MERIT MEDICAL

    Merit Medical is a United States-based public company founded in 1987 with 7,500 employees.

    FRESENIUS MEDICAL CARE AG & CO. KGAA

    Fresenius Medical Care AG & Co. KGaA is a German public company founded in 1996 with 108,165 employees, operating as a major healthcare provider.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees, specializing in medical devices.

    B. BRAUN MELSUNGEN AG

    B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical sectors.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, specializing in medical technology and diagnostics.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees, operating in imaging and medical technology.

    CARDINAL HEALTH

    Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees, operating as a healthcare services and products distributor.

    INTUITIVE SURGICAL

    Intuitive Surgical is a United States-based public company founded in 1995 with 17,021 employees, specializing in robotic surgical systems.

    COLOPLAST A/S

    Coloplast A/S is a Danish public company founded in 1954 with 17,083 employees, specializing in medical devices and healthcare products.

    STRYKER

    Stryker is a United States-based public company founded in 1941 with 56,000 employees, operating in medical technology and surgical equipment.

    TELEFLEX INCORPORATED

    Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees, specializing in medical devices.

    CONVATEC GROUP PLC

    ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees, operating in medical technology and healthcare products.

    MEDTRONIC PLC

    Medtronic PLC is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 7817.4 Million · 4.7% wtd CAGR ·
    Europe
    ~USD 6635.8 Million · 5.6% wtd CAGR ·
    Latin America
    ~USD 2183.6 Million · 3.4% wtd CAGR ·
    Middle East & Africa
    ~USD 1878.5 Million · 3.1% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    ChinaUSD 3880.8 Million
    JapanUSD 2624.9 Million
    IndiaUSD 1227.7 Million
    Rest Of Asia PacificUSD 2877 Million

    Country market size visualization

    China
    USD 3880.8 Million
    Japan
    USD 2624.9 Million
    India
    USD 1227.7 Million
    Rest Of Asia Pacific
    USD 2877 Million

    Reasons to Buy this Report

    • Regional Market Segmentation Data : Gain detailed insights into country-level market sizes across China, Japan, India, and Rest of Asia Pacific, enabling precise market entry strategies and localized business planning for your urology device portfolio.
    • Growth Opportunity Identification : Identify high-growth segments and emerging opportunities within Asia Pacific's 6.3% CAGR market, with specific focus on aging populations, rising healthcare spending, and underserved patient populations in developing economies.
    • Competitive Landscape Intelligence : Understand regional competitive dynamics, manufacturing hubs, distribution channels, and key market players operating across Asia Pacific to inform product positioning and partnership strategies.
    • Regulatory & Reimbursement Insights : Access country-specific regulatory frameworks, reimbursement policies, and healthcare system structures across major Asia Pacific markets to accelerate product launches and market penetration.
    • Strategic Investment Decisions : Make informed capital allocation decisions with comprehensive market forecasts, trend analysis, and risk assessments specific to Asia Pacific's urology devices sector through 2030.

    Frequently asked questions

    What is the current market size of urology devices in Asia Pacific?

    The Asia Pacific urology devices market is valued at $4,049.6 million in 2025.

    What is the projected market size for Asia Pacific urology devices by 2030?

    The Asia Pacific urology devices market is projected to reach $5,508.4 million by 2030.

    What is the CAGR for the Asia Pacific urology devices market?

    The Asia Pacific urology devices market is expected to grow at a CAGR of 6.3% from 2025 to 2030.

    What are the primary growth drivers for Asia Pacific's urology devices market?

    Key growth drivers include aging populations, rising healthcare expenditure, increasing prevalence of urological conditions, and adoption of minimally invasive procedures across Asia Pacific.

    How does Asia Pacific's urology devices market compare to global growth?

    Asia Pacific's 6.3% CAGR exceeds the global CAGR of 6%, indicating stronger regional market momentum and demand for urological devices.

    RESEARCH METHODOLOGY

    This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global urology devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), US Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

    Urology Devices Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the urology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Urology Devices Market : Top-Down and Bottom-Up Approach

    Urology Devices Market Top Down and Bottom Up Approach

    Data Triangulation

    The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Urology is a medical specialty that deals with the physiology, diseases, and disorders of the human urinary tract and male reproductive organs. Urology devices comprise various types of equipment used during the diagnosis, surgery, and treatment of urological diseases, such as chronic kidney diseases, renal failure, urinary stones, benign prostate hyperplasia (BPH), pelvic organ prolapse (POP), prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction.

    Key Stakeholders

    • Manufacturers and Distributors of Urology Devices
    • Hospitals and ASCs
    • Academic Research Institutes
    • Urology Clinics
    • Urology Device Service Providers
    • Venture Capitalists and Investors
    • Clinical Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the urology devices market by product, application, end user, and region
    • To forecast the size of the urology devices market with respect to five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall urology devices market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile the key players in the urology devices market and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
    • To track and analyze competitive developments such as product launches, product approvals, mergers, agreements, collaborations, partnerships, expansions, and acquisitions in the urology devices market
    • To benchmark players within the urology devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

    To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the urology devices market

    Customization Options

    With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

    Portfolio Assessment

    • Product Matrix gives a detailed comparison of the product portfolios of the top five companies.

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Geographical Analysis

    • A further breakdown of the Rest of Europe’s urology devices market into countries
    • A further breakdown of the Rest of Asia Pacific’s urology devices market into countries
    • A further breakdown of Latin America’s urology devices market into countries

    Get the Full Urology Devices Market Report

    Full forecast, segment splits, and company analysis for all Urology Devices Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status